Benefits of Early Systemic Corticosteroid in Clinical Deterioration of Post–COVID-19 Interstitial Lung Disease

Detalles Bibliográficos
Autores principales: An, Tai Joon, Lee, Ye Jin, Park, Ji Eun, Lee, Eung Gu, Kim, Youlim, Kang, Sung-Yoon, Joo, Hyonsoo, Choi, Joon Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Tuberculosis and Respiratory Diseases 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537655/
https://www.ncbi.nlm.nih.gov/pubmed/35950320
http://dx.doi.org/10.4046/trd.2022.0072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537655/
https://www.ncbi.nlm.nih.gov/pubmed/35950320
http://dx.doi.org/10.4046/trd.2022.0072

Ejemplares similares